We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Geneservice Appoints Non-Executive Chairman
News

Geneservice Appoints Non-Executive Chairman

Geneservice Appoints Non-Executive Chairman
News

Geneservice Appoints Non-Executive Chairman

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Geneservice Appoints Non-Executive Chairman"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Geneservice Ltd has announced that the Board of Directors has appointed Dr Andy Richards as non-executive Chairman.

Dr Richards is a well known Biotechnology entrepreneur having been a founder of several Cambridge biotechnology companies including Chiroscience, ArakisCambridge Biotechnology and Daniolabs.

He holds a number of non-executive director positions including Vectura group plc, Daniolabs, BiowisdomBabraham Bioscience Technology and Cancer Research Technology (the commercial arm of CR-UK). 

He is a director of the UK Bioindustry Association and this year was voted both Cambridge Evening News Businessman of the Year as well as one of the Top100 Living Contributors to Biotechnology.

This new appointment follows on from the management buyout of Geneservice from the UK MRC in August 2005. 

On his appointment to the board of Geneservice Dr Richards said, "Geneservice have already demonstrated that they have real potential to develop into a major provider of specialist high quality contract research and reagents to the life sciences and rapidly growing biotechnology industry."

"The strong and committed team that led the management buyout have ambitious plans to grow Geneservice and I am delighted to have the opportunity to help them achieve this."

CEO of Geneservice Dr Tom Weaver added, "We are a young company and our aim was to bring in someone with extensive knowledge of biotechnology and experience with small startup companies."

"Andy’s expertise and networking ability is exactly what we need at this stage of our development, plus he shares our vision to rapidly build up our product and service portfolio."

"His infectious passion for innovation and getting the most out of our people, operations and business opportunities will add so much to our senior management team."

Advertisement